Chesapeake Capital Corp IL Takes Position in Corteva, Inc. $CTVA

Chesapeake Capital Corp IL acquired a new stake in Corteva, Inc. (NYSE:CTVA) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 17,874 shares of the company’s stock, valued at approximately $1,209,000. Corteva accounts for 1.1% of Chesapeake Capital Corp IL’s holdings, making the stock its 17th largest holding.

A number of other institutional investors have also recently bought and sold shares of CTVA. Activest Wealth Management raised its position in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares during the period. True Wealth Design LLC grew its holdings in Corteva by 209.5% during the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares during the period. Total Investment Management Inc. acquired a new position in Corteva during the second quarter valued at approximately $27,000. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva in the second quarter valued at approximately $29,000. Finally, Redmont Wealth Advisors LLC acquired a new stake in Corteva in the third quarter worth $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Down 0.8%

NYSE:CTVA opened at $79.13 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The company has a market cap of $53.22 billion, a PE ratio of 50.08, a PEG ratio of 2.73 and a beta of 0.72. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90. The stock has a 50-day simple moving average of $74.11 and a 200 day simple moving average of $69.24.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 45.57%.

Analyst Upgrades and Downgrades

Several analysts recently commented on CTVA shares. Jefferies Financial Group raised their price objective on Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research note on Monday, March 2nd. Wall Street Zen downgraded Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Citigroup lifted their price objective on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Finally, BNP Paribas Exane boosted their price objective on Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.14% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.